Toni Williamson PhD, BSc

Toni Williamson joined Flexion Therapeutics as Senior Director of Non-Clinical Research in 2015. Prior to joining Flexion, Toni spent 10 years at Amgen, initially managing the Alzheimer’s disease in vivo pharmacology group and leading small molecule drug discovery teams.

She then moved into Toxicology, supporting projects from early discovery to clinical development, predominantly in the Neuroscience Therapeutic Area. Prior to joining Amgen, Toni led the Alzheimer’s disease in vivo biochemistry group at Merck, Sharpe and Dohme, and prior to Merck, she was Head of Biological Models at Trophos, a start-up company focused on neurodegenerative diseases. Toni received her bachelor’s degree in Biochemistry & Physiology from the University of Reading, and her PhD from King’s College London. Toni did her post-doctoral research in Dr. Don Cleveland’s laboratory (UCSD).